Rf360 Europe GmbH
USPTO PatentsView assignee record - 13 granted patents across 7 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H03H (Impedance Networks, e.g. Resonant CIRCUITS; Resonators).
The verdict
According to USPTO PatentsView, Rf360 ranks #21,692 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 7 technology areas.
- #21,692
- of 49,997 US assignees by volume
- Top 11%
- by Innovation Score (51.5/100)
- 21.8
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R21692 · Foreign Corporation #21,692 · 13 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 13 grants
- MID-PACK #21,692/49,997
- PHOTO-FINISH Restek
- CPC-NARROW H03H · 7 areas
- INNOV-PAR 51.5/100
- CLAIMS-DENSE 21.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2021–2024 · 4y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Restek Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Rf360’s 51.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Rf360
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Rf360 Europe · this assignee
Rf360 Europe · this assignee
52 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Rf360's Innovation Score is 51.5/100 (top 11% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Rf360?
Each dot is one of Rf360’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Rf360’s own 21.8 claims/patent is ABOVE the 18.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Rf360's grants concentrate
Rf360 Europe GmbH is a focused PatentsView assignee: 7 CPC subclasses with 76.9% of grants classified under H03H (Impedance Networks, e.g. Resonant CIRCUITS; Resonators). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2021. By volume, Rf360 sits between Restek Corporation and RM Acquisition, LLC.
Rf360's three-year grant acceleration
Rf360 Europe GmbH shows 12 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Rf360's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Restek
Restek Corporation
13 patents
- Reviva Pharmaceut…
Reviva Pharmaceuticals, Inc.
13 patents
- Revivo Medical
Revivo Medical, LLC
13 patents
- Reyco Granning
Reyco Granning, LLC
13 patents
- Rhodia Poliamida…
Rhodia Poliamida E Especialidades S.A.
13 patents
- Ripd IP Developme…
Ripd IP Development Ltd
13 patents
- Ripple Labs
Ripple Labs Inc.
13 patents
- RM Acquisition
RM Acquisition, LLC
13 patents
- Rf360 Europe ◀
Rf360 Europe GmbH
13 patents
What this shows Rf360 holds 13 patents at rank #21,670, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Rf360
By rank, the assignees closest to #21,670 in granted patent volume.
- Restek Corporation #21,666 · 13 patents
- Reviva Pharmaceuticals, Inc. #21,667 · 13 patents
- Revivo Medical, LLC #21,668 · 13 patents
- Reyco Granning, LLC #21,669 · 13 patents
- Rhodia Poliamida E Especialidades S.A. #21,671 · 13 patents
- Ripd IP Development Ltd #21,672 · 13 patents
- Ripple Labs Inc. #21,673 · 13 patents
- RM Acquisition, LLC #21,674 · 13 patents
Leaders in H03H (Impedance Networks)
Other assignees with the most granted patents in Rf360's primary technology class.
Rf360's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 1 | 7.7% |
| 2022 | 5 | 38.5% |
| 2023 | 5 | 38.5% |
| 2024 | 2 | 15.4% |
Which technologies does Rf360 Europe GmbH patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Rf360 Europe GmbH's patent record in context - here's where to go next.
- Rf360 Europe GmbH's lead technology class is H03H (Impedance Networks, e.g. Resonant CIRCUITS; Resonators), 76.9% of its portfolio - see every assignee active in that class. Explore H03H
- Ranked #21,692 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Rf360 Europe GmbH against Restek Corporation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 51.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.